Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Smith

Showing results (281-290 of 292) with videos related to

Pageof 30
Sort By:
Journal of Pediatric Orthopedics|July 29, 2021
Outcomes and Complications in Management of Congenital Myopathy Early-Onset ScoliosisLacey Magee, Joshua T Bram, Jason B Anari, et al.
Science Signaling|December 20, 2018
5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein-coupled receptor DTereza Bautzova, James R F Hockley, Teresa Perez-Berezo, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissueDhruva D Dhavale, Alexander M Barclay, Collin G Borcik, et al.
Nature Neuroscience|December 13, 2016
Small-molecule inhibition of STOML3 oligomerization reverses pathological mechanical hypersensitivityChristiane Wetzel, Simone Pifferi, Cristina Picci, et al.
Breast Cancer Research : BCR|March 15, 2019
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trialStephen K L Chia, Miguel Martin, Frankie A Holmes, et al.
Nature Communications|March 30, 2024
Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissueDhruva D Dhavale, Alexander M Barclay, Collin G Borcik, et al.
The Lancet. Oncology|February 15, 2016
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialArlene Chan, Suzette Delaloge, Frankie A Holmes, et al.
Applied Optics|June 17, 2006
Wide-field Fizeau imaging telescope: experimental resultsR L Kendrick, Jean-Noel Aubrun, Ray Bell, et al.
Nature|April 14, 2022
Somatic mutation rates scale with lifespan across mammalsAlex Cagan, Adrian Baez-Ortega, Natalia Brzozowska, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2018
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting ReportAnat R Tambur, Patricia Campbell, Frans H Claas, et al.
Pageof 30

Showing results (281-290 of 292) with videos related to

Sort By:
Pageof 30
Journal of Pediatric Orthopedics|July 29, 2021
Outcomes and Complications in Management of Congenital Myopathy Early-Onset ScoliosisLacey Magee, Joshua T Bram, Jason B Anari, et al.
Science Signaling|December 20, 2018
5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein-coupled receptor DTereza Bautzova, James R F Hockley, Teresa Perez-Berezo, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissueDhruva D Dhavale, Alexander M Barclay, Collin G Borcik, et al.
Nature Neuroscience|December 13, 2016
Small-molecule inhibition of STOML3 oligomerization reverses pathological mechanical hypersensitivityChristiane Wetzel, Simone Pifferi, Cristina Picci, et al.
Breast Cancer Research : BCR|March 15, 2019
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trialStephen K L Chia, Miguel Martin, Frankie A Holmes, et al.
Nature Communications|March 30, 2024
Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissueDhruva D Dhavale, Alexander M Barclay, Collin G Borcik, et al.
The Lancet. Oncology|February 15, 2016
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialArlene Chan, Suzette Delaloge, Frankie A Holmes, et al.
Applied Optics|June 17, 2006
Wide-field Fizeau imaging telescope: experimental resultsR L Kendrick, Jean-Noel Aubrun, Ray Bell, et al.
Nature|April 14, 2022
Somatic mutation rates scale with lifespan across mammalsAlex Cagan, Adrian Baez-Ortega, Natalia Brzozowska, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2018
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting ReportAnat R Tambur, Patricia Campbell, Frans H Claas, et al.
Pageof 30